• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型取代螺环氧化吲哚的设计与合成及其作为 MDM2-p53 相互作用抑制剂的潜力。

Design and synthesis of new substituted spirooxindoles as potential inhibitors of the MDM2-p53 interaction.

机构信息

Department of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia; Department of Chemistry, Faculty of Science, Alexandria University, P.O. Box 426, Ibrahimia, Alexandria 21321, Egypt.

Department of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.

出版信息

Bioorg Chem. 2019 May;86:598-608. doi: 10.1016/j.bioorg.2019.01.053. Epub 2019 Jan 31.

DOI:10.1016/j.bioorg.2019.01.053
PMID:30802707
Abstract

The designed compounds, 4a-p, were synthesized using a simple and smooth method with an asymmetric 1,3-dipolar reaction as the key step. The chemical structures for all synthesized compounds were elucidated and confirmed by spectral analysis. The molecular complexity and the absolute stereochemistry of 4b and 4e designed analogs were determined by X-ray crystallographic analysis. The anticancer activities of the synthesized compounds were tested against colon (HCT-116), prostate (PC-3), and hepatocellular (HepG-2) cancer cell lines. Molecular modeling revealed that the compound 4d binds through hydrophobic-hydrophobic interactions with the essential amino acids (LEU: 57, GLY: 58, ILE: 61, and HIS: 96) in the p53-binding cleft, as a standard p53-MDM2 inhibitor (6SJ). The mechanism underlying the anticancer activity of compound 4d was further evaluated, and the study showed that compound 4d inhibited colony formation, cell migration, arrested cancer cell growth at G2/M, and induced apoptosis through intrinsic and extrinsic pathways. Transactivation of p53 was confirmed by flow cytometry, where compound 4d increased the level of activated p53 and induced mRNA levels of cell cycle inhibitor, p21.

摘要

设计的化合物 4a-p 通过一种简单而流畅的方法合成,其中不对称 1,3-偶极反应是关键步骤。所有合成化合物的化学结构均通过光谱分析阐明和确认。通过 X 射线晶体学分析确定了化合物 4b 和 4e 设计类似物的分子复杂性和绝对立体化学。合成化合物的抗癌活性针对结肠(HCT-116)、前列腺(PC-3)和肝细胞(HepG-2)癌细胞系进行了测试。分子建模表明,化合物 4d 通过疏水-疏水相互作用与 p53 结合凹槽中的必需氨基酸(LEU:57、GLY:58、ILE:61 和 HIS:96)结合,作为标准的 p53-MDM2 抑制剂(6SJ)。进一步评估了化合物 4d 抗癌活性的机制,研究表明,化合物 4d 通过内在和外在途径抑制集落形成、细胞迁移、将癌细胞生长阻滞在 G2/M 期并诱导细胞凋亡。通过流式细胞术证实了 p53 的转导活性,其中化合物 4d 增加了激活的 p53 水平并诱导了细胞周期抑制剂 p21 的 mRNA 水平。

相似文献

1
Design and synthesis of new substituted spirooxindoles as potential inhibitors of the MDM2-p53 interaction.新型取代螺环氧化吲哚的设计与合成及其作为 MDM2-p53 相互作用抑制剂的潜力。
Bioorg Chem. 2019 May;86:598-608. doi: 10.1016/j.bioorg.2019.01.053. Epub 2019 Jan 31.
2
One-pot synthesis of spiro(indoline-3,4'-pyrazolo[3,4-b]pyridine)-5'-carbonitriles as p53-MDM2 interaction inhibitors.一锅法合成螺(吲哚啉-3,4'-吡唑并[3,4-b]吡啶)-5'-碳腈作为 p53-MDM2 相互作用抑制剂。
Future Med Chem. 2018 Dec;10(24):2771-2789. doi: 10.4155/fmc-2018-0288. Epub 2018 Dec 10.
3
Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators.新型基于螺环吲哚的 MDM2 抑制剂的分子杂交设计与合成,具有 BCL2 信号衰减作用;向着新一代 p53 激活剂迈进了一步。
Bioorg Chem. 2021 Dec;117:105427. doi: 10.1016/j.bioorg.2021.105427. Epub 2021 Oct 13.
4
Design, Synthesis, and Anti-cervical Cancer Activity of a Novel MDM2-p53 Inhibitor Based on a Chalcone Scaffold.基于查尔酮骨架的新型 MDM2-p53 抑制剂的设计、合成及抗宫颈癌活性研究。
Anticancer Agents Med Chem. 2024;24(6):423-435. doi: 10.2174/0118715206274066231220071557.
5
Synthesis of new thiazolo-pyrrolidine-(spirooxindole) tethered to 3-acylindole as anticancer agents.合成新型噻唑并吡咯烷-(螺吲哚)连接 3-乙酰基吲哚作为抗癌剂。
Bioorg Chem. 2019 Feb;82:423-430. doi: 10.1016/j.bioorg.2018.10.036. Epub 2018 Oct 23.
6
Design, synthesis, and biological evaluation of imidazoline derivatives as p53-MDM2 binding inhibitors.设计、合成及咪唑啉衍生物作为 p53-MDM2 结合抑制剂的生物评价。
Bioorg Med Chem. 2011 Sep 15;19(18):5454-61. doi: 10.1016/j.bmc.2011.07.050. Epub 2011 Jul 30.
7
Design, synthesis and biological evaluation of novel antitumor spirotetrahydrothiopyran-oxindole derivatives as potent p53-MDM2 inhibitors.新型抗肿瘤螺四氢噻喃-氧化吲哚衍生物作为高效p53-MDM2抑制剂的设计、合成及生物学评价
Bioorg Med Chem. 2017 Oct 15;25(20):5268-5277. doi: 10.1016/j.bmc.2017.07.049. Epub 2017 Jul 28.
8
Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction.基于结构的螺环氧化吲哚类化合物设计,作为MDM2-p53相互作用的强效、特异性小分子抑制剂。
J Med Chem. 2006 Jun 15;49(12):3432-5. doi: 10.1021/jm051122a.
9
Spiro-oxindoles as a Promising Class of Small Molecule Inhibitors of p53-MDM2 Interaction Useful in Targeted Cancer Therapy.螺环-氧吲哚类作为一种有前途的小分子 p53-MDM2 相互作用抑制剂用于靶向癌症治疗。
Top Curr Chem (Cham). 2017 Feb;375(1):3. doi: 10.1007/s41061-016-0089-0. Epub 2016 Dec 9.
10
Design, synthesis and biological evaluation of novel pyrrolidone-based derivatives as potent p53-MDM2 inhibitors.新型基于吡咯烷酮的衍生物的设计、合成及作为强效 p53-MDM2 抑制剂的生物评价。
Bioorg Chem. 2021 Oct;115:105268. doi: 10.1016/j.bioorg.2021.105268. Epub 2021 Aug 17.

引用本文的文献

1
The Therapeutic Potential of Spirooxindoles in Cancer: A Focus on p53-MDM2 Modulation.螺环氧化吲哚类化合物在癌症治疗中的潜力:聚焦于p53-MDM2调控
Pharmaceuticals (Basel). 2025 Feb 19;18(2):274. doi: 10.3390/ph18020274.
2
Nanoformulation of Spirooxindole and Methods for Treating Hepatocellular Carcinoma.螺环氧化吲哚的纳米制剂及治疗肝细胞癌的方法。
Pharmaceutics. 2025 Jan 12;17(1):93. doi: 10.3390/pharmaceutics17010093.
3
An Azomethine Derivative, BCS3, Targets XIAP and cIAP1/2 to Arrest Breast Cancer Progression Through MDM2-p53 and Bcl-2-Caspase Signaling Modulation.
一种偶氮甲碱衍生物BCS3,通过MDM2-p53和Bcl-2-半胱天冬酶信号调节作用靶向X连锁凋亡抑制蛋白(XIAP)和细胞凋亡抑制蛋白1/2(cIAP1/2)以阻止乳腺癌进展。
Pharmaceuticals (Basel). 2024 Dec 6;17(12):1645. doi: 10.3390/ph17121645.
4
Natural product-inspired [3 + 2] cycloaddition-based spirooxindoles as dual anticancer agents: synthesis, characterization, and biological evaluation by and methods.基于天然产物灵感的[3 + 2]环加成反应的螺环氧化吲哚类双功能抗癌剂:合成、表征及通过[具体方法1]和[具体方法2]进行的生物学评价
RSC Med Chem. 2024 Oct 11;16(1):137-56. doi: 10.1039/d4md00634h.
5
Quantitative structure-activity relationship and ADME prediction studies on series of spirooxindoles derivatives for -cancer activity against colon cancer cell line HCT-116.针对一系列螺环氧化吲哚衍生物对结肠癌细胞系HCT - 116的抗癌活性的定量构效关系及药物代谢动力学预测研究。
Heliyon. 2024 Aug 8;10(16):e35897. doi: 10.1016/j.heliyon.2024.e35897. eCollection 2024 Aug 30.
6
Activation of p53 signaling and regression of breast and prostate carcinoma cells by spirooxindole-benzimidazole small molecules.螺环氧化吲哚-苯并咪唑小分子激活p53信号通路并促使乳腺癌和前列腺癌细胞消退。
Front Pharmacol. 2024 Apr 8;15:1358089. doi: 10.3389/fphar.2024.1358089. eCollection 2024.
7
Reinvestigation of diphenylmethylpiperazine analogues of pyrazine as new class of cysteine protease inhibitors for the treatment of malaria.重新研究吡嗪的二苯甲基哌嗪类似物作为治疗疟疾的新型半胱氨酸蛋白酶抑制剂。
RSC Med Chem. 2024 Feb 1;15(3):1022-1037. doi: 10.1039/d3md00490b. eCollection 2024 Mar 20.
8
Diastereoselective Synthesis of Dispiro[Imidazothiazolotriazine-Pyrrolidin-Oxindoles] and Their Isomerization Pathways in Basic Medium.在碱性介质中,非对映选择性合成双螺[咪唑并噻唑并吡咯并吲哚]及其异构化途径。
Int J Mol Sci. 2023 Nov 15;24(22):16359. doi: 10.3390/ijms242216359.
9
Recent synthetic strategies of spiro-azetidin-2-one, -pyrrolidine, -indol(one) and -pyran derivatives-a review.螺氮杂环丁烷-2-酮、吡咯烷、吲哚(酮)和吡喃衍生物的近期合成策略——综述
RSC Adv. 2023 Nov 7;13(46):32786-32823. doi: 10.1039/d3ra06054c. eCollection 2023 Oct 31.
10
Molecular Docking and Molecular Dynamics Studies Reveal the Anticancer Potential of Medicinal-Plant-Derived Lignans as MDM2-P53 Interaction Inhibitors.分子对接和分子动力学研究揭示药用植物来源的木脂素作为 MDM2-P53 相互作用抑制剂的抗癌潜力。
Molecules. 2023 Sep 16;28(18):6665. doi: 10.3390/molecules28186665.